Legis Daily

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

USA118th CongressHR-124| House 
| Updated: 1/20/2023
Al Green

Al Green

Democratic Representative

Texas

Cosponsors (3)
Don Bacon (Republican)Eleanor Holmes Norton (Democratic)Bennie G. Thompson (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 117-124
Byron Nash Renal Medullary Carcinoma Awareness Act of 2021

Bill from Previous Congress

HR 116-148
Byron Nash Renal Medullary Carcinoma Awareness Act of 2019
Jan 9, 2023
Introduced in House
Jan 9, 2023
Referred to the House Committee on Energy and Commerce.
Jan 20, 2023
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 117-124
    Byron Nash Renal Medullary Carcinoma Awareness Act of 2021


  • Bill from Previous Congress

    HR 116-148
    Byron Nash Renal Medullary Carcinoma Awareness Act of 2019


  • January 9, 2023
    Introduced in House


  • January 9, 2023
    Referred to the House Committee on Energy and Commerce.


  • January 20, 2023
    Referred to the Subcommittee on Health.

Health

CancerDigestive and metabolic diseasesHealth promotion and preventive careMedicaid

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

USA118th CongressHR-124| House 
| Updated: 1/20/2023
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 117-124
Byron Nash Renal Medullary Carcinoma Awareness Act of 2021

Bill from Previous Congress

HR 116-148
Byron Nash Renal Medullary Carcinoma Awareness Act of 2019
Jan 9, 2023
Introduced in House
Jan 9, 2023
Referred to the House Committee on Energy and Commerce.
Jan 20, 2023
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 117-124
    Byron Nash Renal Medullary Carcinoma Awareness Act of 2021


  • Bill from Previous Congress

    HR 116-148
    Byron Nash Renal Medullary Carcinoma Awareness Act of 2019


  • January 9, 2023
    Introduced in House


  • January 9, 2023
    Referred to the House Committee on Energy and Commerce.


  • January 20, 2023
    Referred to the Subcommittee on Health.
Al Green

Al Green

Democratic Representative

Texas

Cosponsors (3)
Don Bacon (Republican)Eleanor Holmes Norton (Democratic)Bennie G. Thompson (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
CancerDigestive and metabolic diseasesHealth promotion and preventive careMedicaid